Expert panel highlights patient choice for prostate cancer screen (Update)

by Dennis Thompson, Healthday ReporterMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0(HealthDay)—More men could receiv

Updated on: April 01,2024

Expert panel highlights patient choice for prostate cancer screen (Update)

by Dennis Thompson, Healthday ReporterMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0(HealthDay)—More men could receiv

Updated on:April 01,2024

Risk-taking behavior on roads in Victoria, Australia increased during lockdowns, study shows

by Monash UniversityCredit: Pixabay/CC0 Public DomainReduced travel on Victoria's roads during the COVID-19 pandemic did not equate to proportionate reductions in road trauma.New research&nbs

Updated on: May 31,2024

Risk-taking behavior on roads in Victoria, Australia increased during lockdowns, study shows

by Monash UniversityCredit: Pixabay/CC0 Public DomainReduced travel on Victoria's roads during the COVID-19 pandemic did not equate to proportionate reductions in road trauma.New research&nbs

Updated on:May 31,2024

AI-powered ultrasound imaging that detects breast cancer

by Pohang University of Science & Technology (POSTECH)Research Image. Credit: POSTECHBreast cancer undisputedly has the highest incidence rate in female patients. Moreover, out of the six major ca

Updated on: February 19,2024

AI-powered ultrasound imaging that detects breast cancer

by Pohang University of Science & Technology (POSTECH)Research Image. Credit: POSTECHBreast cancer undisputedly has the highest incidence rate in female patients. Moreover, out of the six major ca

Updated on:February 19,2024

AI better than human eye at predicting brain metastasis outcomes, find researchers

by York UniversityArchitecture of (a) vanilla 3D residual network (baseline), (b) the 3D residual network with CBAM attention, (c) the proposed self-attention-guided 3D residual network, (d) the

Updated on: February 20,2024

AI better than human eye at predicting brain metastasis outcomes, find researchers

by York UniversityArchitecture of (a) vanilla 3D residual network (baseline), (b) the 3D residual network with CBAM attention, (c) the proposed self-attention-guided 3D residual network, (d) the

Updated on:February 20,2024

Study validates first-ever predictive AI biomarker of androgen deprivation therapy benefit in prostate cancer

by University Hospitals Cleveland Medical CenterProstate cancer cells. Credit: NIH Image GalleryData from a new study published inNEJM Evidenceshows promise for personalized use of sh

Updated on: February 20,2024

Study validates first-ever predictive AI biomarker of androgen deprivation therapy benefit in prostate cancer

by University Hospitals Cleveland Medical CenterProstate cancer cells. Credit: NIH Image GalleryData from a new study published inNEJM Evidenceshows promise for personalized use of sh

Updated on:February 20,2024

A non-coding RNA lasso catches proteins in breast cancer cells

by Lisbeth Heilesen,Aarhus UniversityThe authors show that the long non-coding RNA called A-ROD (Activating Regulator Of DKK1 expression) is only functional the moment it is released from chroma

Updated on: May 20,2024

A non-coding RNA lasso catches proteins in breast cancer cells

by Lisbeth Heilesen,Aarhus UniversityThe authors show that the long non-coding RNA called A-ROD (Activating Regulator Of DKK1 expression) is only functional the moment it is released from chroma

Updated on:May 20,2024

Stomach cancers make electrical connections with the nervous system to fuel spread, study finds

Updated on: April 29,2025

Stomach cancers make electrical connections with the nervous system to fuel spread, study finds

Updated on:April 29,2025

New potential cancer-driving genes identified, opening new paths for precision treatments

byInstitute of Cancer ResearchStudy design and number of samples per tumor type included in the analysis. Credit:Nature Genetics(2024). DOI: 10.1038/s41588-024-01785-9Researchers hav

Updated on: December 01,2024

New potential cancer-driving genes identified, opening new paths for precision treatments

byInstitute of Cancer ResearchStudy design and number of samples per tumor type included in the analysis. Credit:Nature Genetics(2024). DOI: 10.1038/s41588-024-01785-9Researchers hav

Updated on:December 01,2024

Cancer incidence alarming among young people in Middle East, researcher finds

by University of SharjahCredit: Unsplash/CC0 Public DomainCancer cases are unusually high among middle aged people in the Middle East contrary to western countries where they usually hit people a

Updated on: February 03,2024

Cancer incidence alarming among young people in Middle East, researcher finds

by University of SharjahCredit: Unsplash/CC0 Public DomainCancer cases are unusually high among middle aged people in the Middle East contrary to western countries where they usually hit people a

Updated on:February 03,2024

Researcher recommends tailoring colorectal cancer screening for 45-to-49-year-olds

by Regenstrief InstituteCredit: Pixabay/CC0 Public DomainIt's been a year since national recommendations issued by the American Cancer Society and the U.S. Multi-Society Task Force called for

Updated on: January 30,2024

Researcher recommends tailoring colorectal cancer screening for 45-to-49-year-olds

by Regenstrief InstituteCredit: Pixabay/CC0 Public DomainIt's been a year since national recommendations issued by the American Cancer Society and the U.S. Multi-Society Task Force called for

Updated on:January 30,2024

Some cervical cancer screening strategies more cost-effective

(HealthDay)—A cervical cancer screening strategy that involves cytologic testing every three years from ages 21 to 29 years and then continuing cytologic testing or switching to low-cost high-risk hum

Updated on: May 21,2024

Some cervical cancer screening strategies more cost-effective

(HealthDay)—A cervical cancer screening strategy that involves cytologic testing every three years from ages 21 to 29 years and then continuing cytologic testing or switching to low-cost high-risk hum

Updated on:May 21,2024

AACR: Cadonilimab plus chemo beneficial for gastric adenocarcinoma

by Elana GotkineFor patients with gastric/gastroesophageal junction (G/GEJ) adenocarcinoma, cadonilimab plus chemotherapy is associated with improved overall survival and progression-free survival, ac

Updated on: April 28,2024

AACR: Cadonilimab plus chemo beneficial for gastric adenocarcinoma

by Elana GotkineFor patients with gastric/gastroesophageal junction (G/GEJ) adenocarcinoma, cadonilimab plus chemotherapy is associated with improved overall survival and progression-free survival, ac

Updated on:April 28,2024